
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
57%
Total
Publications
1.3K
Total Open
Publications
766
Total
Citations
37K
Open Access
Percentage
57%
Total
Publications
1.3K
Total Open
Publications
766
Total
Citations
37K
Breakdown
Publisher Open
23%
Both
28%
Other Platform Open
6%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
250
Hybrid 27%
189
No Guarantees 37%
256
Other Platform Open
Domain 72%
330
Institution 59%
273
Other Internet 14%
62
Preprint 6%
29
Public 2%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 334 |
doaj.org OAI-PMH Repository | Institution | 123 |
DOI | Other Internet | 44 |
University of Groningen | Institution | 36 |
Unknown Repository | Other Internet | 23 |
Europe PMC | Domain | 16 |
University of Zurich | Institution | 15 |
epfl.ch OAI-PMH Repository | Institution | 15 |
Asklepios Klinik St. Georg | Institution | 13 |
kuleuven.be OAI-PMH Repository | Institution | 11 |